| Year |
Citation |
Score |
| 2023 |
Macvanin M, Gluvic Z, Klisic A, Manojlovic M, Suri J, Rizzo M, Isenovic E. The Link between miRNAs and PCKS9 in Atherosclerosis. Current Medicinal Chemistry. PMID 37990898 DOI: 10.2174/0109298673262124231102042914 |
0.545 |
|
| 2023 |
Tomic AZ, Zafirovic SS, Gluvic ZM, Samardzic VS, Macvanin MT, Radunovic ML, Isenovic ER. Subacute thyroiditis following COVID-19 vaccination: Case presentation. Antiviral Therapy. 28: 13596535231208831. PMID 37861754 DOI: 10.1177/13596535231208831 |
0.507 |
|
| 2023 |
Lukic N, Macvanin MT, Gluvic Z, Rizzo M, Radak D, Suri JS, Isenovic ER. SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus. Current Medicinal Chemistry. PMID 37855338 DOI: 10.2174/0109298673251493231011192520 |
0.503 |
|
| 2023 |
Samardzic VS, Macvanin MT, Zafirovic SS, Obradovic MM, Gluvic ZM, Grubin J, Gao X, Essack M, Isenovic ER. Nitric oxide, thyroglobulin, and calcitonin: unraveling the nature of thyroid nodules. Frontiers in Endocrinology. 14: 1241223. PMID 37842300 DOI: 10.3389/fendo.2023.1241223 |
0.497 |
|
| 2023 |
Macvanin MT, Gluvic Z, Bajic V, Isenovic ER. Novel insights regarding the role of noncoding RNAs in diabetes. World Journal of Diabetes. 14: 958-976. PMID 37547582 DOI: 10.4239/wjd.v14.i7.958 |
0.567 |
|
| 2023 |
Macvanin MT, Gluvic ZM, Zaric BL, Essack M, Gao X, Isenovic ER. New biomarkers: prospect for diagnosis and monitoring of thyroid disease. Frontiers in Endocrinology. 14: 1218320. PMID 37547301 DOI: 10.3389/fendo.2023.1218320 |
0.531 |
|
| 2023 |
Macvanin MT, Gluvic Z, Radovanovic J, Essack M, Gao X, Isenovic ER. Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAs. Frontiers in Endocrinology. 14: 1124613. PMID 36950696 DOI: 10.3389/fendo.2023.1124613 |
0.542 |
|
| 2023 |
Macvanin M, Gluvic Z, Radovanovic J, Essack M, Gao X, Isenovic ER. New insights on the cardiovascular effects of IGF-1. Frontiers in Endocrinology. 14: 1142644. PMID 36843588 DOI: 10.3389/fendo.2023.1142644 |
0.474 |
|
| 2023 |
Macvanin MT, Zafirovic S, Obradovic M, Isenovic ER. Editorial: Non-coding RNA in diabetes and cardiovascular diseases. Frontiers in Endocrinology. 14: 1149857. PMID 36814579 DOI: 10.3389/fendo.2023.1149857 |
0.506 |
|
| 2023 |
Alamro H, Bajic V, Macvanin MT, Isenovic ER, Gojobori T, Essack M, Gao X. Type 2 Diabetes Mellitus and its comorbidity, Alzheimer's disease: Identifying critical microRNA using machine learning. Frontiers in Endocrinology. 13: 1084656. PMID 36743910 DOI: 10.3389/fendo.2022.1084656 |
0.494 |
|
| 2023 |
Macvanin MT, Gluvic Z, Zafirovic S, Gao X, Essack M, Isenovic ER. The protective role of nutritional antioxidants against oxidative stress in thyroid disorders. Frontiers in Endocrinology. 13: 1092837. PMID 36686463 DOI: 10.3389/fendo.2022.1092837 |
0.55 |
|
| 2022 |
Zaric BL, Macvanin MT, Isenovic ER. Free radicals: Relationship to Human Diseases and Potential Therapeutic applications. The International Journal of Biochemistry & Cell Biology. 154: 106346. PMID 36538984 DOI: 10.1016/j.biocel.2022.106346 |
0.514 |
|
| 2022 |
Macvanin MT, Rizzo M, Radovanovic J, Sonmez A, Paneni F, Isenovic ER. Role of Chemerin in Cardiovascular Diseases. Biomedicines. 10. PMID 36428537 DOI: 10.3390/biomedicines10112970 |
0.528 |
|
| 2022 |
Zafirovic S, Macvanin M, Stanimirovic J, Obradovic M, Radovanovic J, Melih I, Isenovic ER. Association between telomere length and cardiovascular risk: Pharmacological treatments affecting telomeres and telomerase activity. Current Vascular Pharmacology. PMID 35986545 DOI: 10.2174/1570161120666220819164240 |
0.499 |
|
| 2022 |
Macvanin M, Obradovic M, Zafirovic S, Stanimirovic J, Isenovic ER. The role of miRNAs in metabolic diseases. Current Medicinal Chemistry. PMID 35927902 DOI: 10.2174/0929867329666220801161536 |
0.545 |
|
| 2010 |
Macvanin M, Hughes D.. Assays of sensitivity of antibiotic-resistant bacteria to hydrogen peroxide and measurement of catalase activity Methods Mol Biol.. 642: 95-193. PMID 20401588 DOI: 10.1007/978-1-60327-279-7_7 |
0.529 |
|
| 2005 |
Macvanin M, Hughes D.. Hyper-susceptibility of a fusidic acid-resistant mutant of Salmonella to different classes of antibiotics Fems Microbiol Lett. 2005 Jun 15;247(2):215-20. Doi:. 247: 215-220. PMID 15935566 DOI: 10.1016/j.femsle.2005.05.007 |
0.508 |
|
| 2004 |
Macvanin M, Ballagi A, Hughes D.. Fusidic acid-resistant mutants of Salmonella enterica serovar typhimurium have low levels of heme and a reduced rate of respiration and are sensitive to oxidative stress Antimicrob Agents Chemother.. 48: 3877-3883. PMID 15388448 DOI: 10.1128/AAC.48.10.3877-3883.2004 |
0.53 |
|
| Show low-probability matches. |